PTC Gets $1bn From Novartis For Phase II Huntington’s Candidate

 
• By Joseph Haas
  
Novartis NIBR Cambridge, MA
Novartis adds another Huntington's disease candidate
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Therapy Areas